PharVision Advisers’s Navigator Holdings NVGS Stock Holding History

PharVision Advisers’s Portfolio NVGS Stock Details NVGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,751	Closed	-$609K	–	378
2025 Q1	$609K	Buy	+45,751	New	+$711K	0.84%	4

Other funds holding NVGS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Robotti Robert $641M AUM 66.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAM

Steinberg Asset Management New York $154M AUM 41.94% 1-Year Est. Return

PharVision Advisers's NVGS Position: Q2 2025 in Review

PharVision Advisers sold out of Navigator Holdings (NVGS) in Q2 2025, closing a stake of 45,751 shares — an estimated $609K sold.

PharVision Advisers first reported a position in NVGS in Q1 2025 and held it in 1 quarter. The position peaked at $609K in Q1 2025. 118 funds tracked by Wall St. Rank hold NVGS as of Q2 2025.

PharVision Advisers reported no remaining Navigator Holdings position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 45,751 Navigator Holdings shares in Q2 2025, an estimated $609K.
PharVision Advisers first reported a position in Navigator Holdings in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Navigator Holdings position peaked at $609K in Q1 2025.
118 funds tracked by Wall St. Rank held Navigator Holdings as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.